Ropes & Gray represented Genesis Therapeutics in the transaction. Genesis Therapeutics completed a $52 million Series A financing round to accelerate artificial intelligence innovation and to…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
